Open Access

The science of HDL and reverse cholesterol transport – Are we still hopeful?

Topic: Metabolism and metabolic syndromes
Sponsored by Cleveland Clinic

Presentation

About the speaker

Professor John Kastelein

University of Amsterdam, Amsterdam (Netherlands (The))
20 presentations
1 follower

3 more presentations in this session

Unmet medical needs with current agents and residual CV risk: rationale for developing new agents.

Speaker: Professor S. Nissen (Cleveland, US)

Thumbnail

New horizons for the statin intolerant patients: current and future therapeutic options.

Speaker: Doctor L. Cho (Cleveland, US)

Thumbnail

Prospects for clinical benefit with CETP inhibition in light of current and future trials.

Speaker: Professor A. Lincoff (Cleveland, US)

Thumbnail

Access the full session

Cardiovascular risk reduction and lipid management: state of the science

Speakers: Professor J. Kastelein, Professor S. Nissen, Doctor L. Cho, Professor A. Lincoff
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk